How Eclipse Trials Turns Your Clinical Trial Data into a Powerful Asset

How Eclipse Trials Turns Your Clinical Trial Data into a Powerful Asset

About this webinar

  • Learn how this software enables drug innovation & data transparency

  • See how you can anonymize clinical trial data quickly, safely & at scale

Your structured clinical trial data is an increasingly valuable resource that benefits new analytics, research, and innovation. With the pressure being put on pharma to collaborate and share trial data, your organization wants to step up and contribute, but:

  • Patient-level data contains large amounts of sensitive information
  • Regulators and the public need to see that privacy is protected
  • Protecting privacy often means losing data utility

Fortunately, Privacy Analytics can help you overcome each of these challenges.

Join Ron Kaine, Software Product Manager, and Niamh McGuinness, CTT Anonymization Expert, in this on-demand webinar as they discuss proven ways to solve a range of challenges specific to clinical trial data anonymization.

Whether you’re looking for in-house capabilities, an outsourced solution, or a hybrid of both, you’ll discover how Eclipse Trials software is purpose-built to help life sciences companies like yours get there, faster.

Learn how your business can lean on Privacy Analytics’ software and services to:

  • Drive innovation by accelerating data science
  • Safely achieve clinical trial transparency at scale
  • Quickly fuel your data platform and sharing capabilities

Presenters:

Ron Kaine, Software Product Manager, Privacy Analytics
Niamh McGuinness, Privacy Expert, Privacy Analytics

Fill in the form below to view the webinar.

Sign me up for marketing communications on safely leveraging my sensitive data.

About this webinar

  • Learn how this software enables drug innovation & data transparency

  • See how you can anonymize clinical trial data quickly, safely & at scale

Your structured clinical trial data is an increasingly valuable resource that benefits new analytics, research, and innovation. With the pressure being put on pharma to collaborate and share trial data, your organization wants to step up and contribute, but:

  • Patient-level data contains large amounts of sensitive information
  • Regulators and the public need to see that privacy is protected
  • Protecting privacy often means losing data utility

Fortunately, Privacy Analytics can help you overcome each of these challenges.

Join Ron Kaine, Software Product Manager, and Niamh McGuinness, CTT Anonymization Expert, in this on-demand webinar as they discuss proven ways to solve a range of challenges specific to clinical trial data anonymization.

Whether you’re looking for in-house capabilities, an outsourced solution, or a hybrid of both, you’ll discover how Eclipse Trials software is purpose-built to help life sciences companies like yours get there, faster.

Learn how your business can lean on Privacy Analytics’ software and services to:

  • Drive innovation by accelerating data science
  • Safely achieve clinical trial transparency at scale
  • Quickly fuel your data platform and sharing capabilities

Presenters:

Ron Kaine, Software Product Manager, Privacy Analytics
Niamh McGuinness, Privacy Expert, Privacy Analytics

Click here to view our solution brief.

Presenter(s)

Niamh McGuinness is an expert in clinical trial document submissions and a senior member of the Privacy Analytics team, focused on Clinical Trial Transparency (CTT). She has personally managed many successful projects, with documents representing hundreds of clinical trials. Under her watch, no client has ever missed a regulatory submission deadline or a deadline to make their trial data publicly available.

Niamh’s team works with a variety of clinical trial sponsors that have turned to Privacy Analytics to meet the stringent requirements of regulations such as EMA Policy 0070, Health Canada Public Release of Clinical Information (PRCI), and EU CTR.

Niamh McGuinness, PhD

Associate Director, Safety, Regulatory & Transparency

Read Full Bio

Archiving / Destroying

Are you unleashing the full value of data you retain?

Your Challenges

Do you need help...

  • Unleashing the full value of retained data so they can be put to work safely and responsibly in line with privacy regulation?
  • Defining and implementing effective archival and disposal processes for personal data?

OUR SOLUTION

Value Retention

  • Retain the business value in your data through anonymization.
  • Ensure compliance in your retention & destruction strategy.
  • Maximize the reuse of information by removing what is personal.

Client Success

Client: Comcast

Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.

Read the full story >

Evaluating

Are you achieving intended outcomes from data?

Your Challenge

Do you need help...

  • Optimizing the use / analysis of data to achieve your organization’s intended outcomes with measured success?

OUR SOLUTION

Unbiased Results

  • Reduce / minimize risk of bias in your data for machine learning.
  • Ensure transparency, fairness, and AI ethics / compliance.
  • Ensure data ethics & compliance in your data models and results.

Client Success

Client: Integrate.ai

Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.

Read the full story >

Accessing

Do the right people have the right data?

Your Challenges

Do you need help...

  • Ensuring the right people have access to the right data at the right times?

OUR SOLUTION

Usable and Reusable Data

  • Enable internal access and / or external sharing of data for primary and / or secondary uses.
  • Ensure data are useful and reusable in alignment with FAIR principles.
  • Ensure data have the right level of privacy protection for the use.

Client Success

Client: Novartis

Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.

 

See the full story >

Maintaining

Are you empowering people to safely leverage trusted data?

Your Challenges

Do you need help...

  • Maintaining / processing data securely and efficiently to promote data enablement with auditable proof of compliance?

OUR SOLUTION

Security / compliance efficiency

  • Creating synthetic versions of data to be used for innovation / AIML.
  • Applying data minimization principles to reduce your risk exposure.
  • Transforming your data for secondary uses and access.

CLIENT SUCCESS

Client: ASCO’s CancerLinQ

Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.

 

Visit ASCOPubs.org to read the full story >

Acquiring / Collecting

Are you acquiring the right data? Do you have appropriate consent?

Your Challenge

Do you need help...

  • Ensuring the acquisition / collection of the right data under the appropriate consent / contracts to maintain corporate integrity?

OUR SOLUTIONS

Consent / Contracting strategy

  • Developing a consent / contractual framework for collecting / sourcing.
  • Creating a comms strategy for internal / external stakeholders.
  • Ingesting and transforming data safely to earn trust.

Client Success

Client: IQVIA

Situation: Needed to ensure the primary market research process was fully compliant with internal policies and regulations such as GDPR. 

 

Read the full story >

Planning

Are You Effectively Planning for Success?

Your Challenges

Do you need help...

  • Defining a clear data strategy to achieve desired outcomes?
  • Getting it right at the start to avoid costly privacy missteps later?

OUR SOLUTION

Build privacy in by design

  • Building privacy into your data plan / platform / pipeline upfront.
  • Establishing a trusted data strategy (ethics, compliance, privacy).

Client Success

Client: Nuance

Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.

 

Visit Nuance.com to read the full story >

Join the next 5 Safes Data Privacy webinar

This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.

Register Now